ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000206.1|Chartreusin_1 # 88 # 1407 # -1 # ID=1_1;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.675	BGC0000206.1|Chartreusin_1 	88	1407	-	Loose	850	27.7202	tet(38)	30.77	3000565	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACGTCCAGTCAGGAAATGGCAGCGCACACGGACCGGGCGGTGAAGACATCGCCGTCCGTCGCGGACCGGTGGACGCGGCACCGGTCCTCGCTCCTCGCCGTCGCCACGATCGCCGTCGTCGCCGTGATCGCCCGGTTCGCCTTCCTGGACCACAGGTCCGAGGACTACGTCGACTTCTACCGCCGCTGGTACCAGTTCATCGAGGACAACGGGGGCTACCGCGCGCTGCGGCACCAGTTCTCCAACTACAACGTGCCCTACCTTTATCTGCTCGCGACGACCGTATGGCTGAAGATCCCCTCGCTGGTCGCGGTGAAGCTGATCCCGATCGCGTTCGACGTGCTGCTCGGCTGGTACGTGTACCGGATCACCAGGCTCCGGTATCCGACCGGCCGGCTCCCGCTCACGGCGGCGCTCGTGGTCGTGCTGCTTCCGACGGTCGTGCTGAACAGCTCCATGTGGGGTCAGTGCGACTCCGGTTATGCCGCCCTGGCGATCGGCGGGCTGTACCACCTCATGCGGGGCAGGTCGTGGACGGCGTGCGCCCTGTTCGGCGCGGCGTTCGCCTTCAAGCTCCAGGCCGTCTTCCTGTTCCCGGTCCTGCTGCTGATGGTGCTGCGCCGCAAGCTGCCCTGGCAGTGCCTGCTCGCTGTTCCCGGCATGTATCTGCTGCTCGACGTCCCGGCGCTGCTGCTGGGCGCCGAGCCGGGGAAACTGCTCACCGTCTACCTCGACCAGGCGTCGCTGCTGCACGGCGAGTTCATCGTGACCGCCCCCAACGCCTTCCAGTACCTGGACTCCACGCCACAGGTCCTTCAGACGCTGGGGATCGTGCTGACCGGGGTGTCGGTGCTCGGACTGGTCGGCGCGGCGGTGCTGCGCCGTCCCAACCTGACGCACCTCCAGCTGGTGCTGGCGGCTGCGGTCTCGGCGCTGCTGGTGCCGTTCCTGCTGCCCAACATGCACGAGCGGTACTTCTACCTCGCCGACGTGCTCACGGTGATCGCCGCGTTCTGGCTCCCCCGCAAGCTCTGGTTCGCGCCGCTCCTCACACAGTTCGCCTCCCTGTTCGCCTACATCCCGTTCCTGCTGCTGCCGTACCGGCTGCGCGACCTCACCGGGAATCCGGACGTCGTTGGCGGATCCGGCTTCGCCGAGCCGGCACCGGAGATCCGGCTGGCTTGCGTCGGCGATACGTCTCGGCCCCAGCCCGCGGGAGGTGCTCGCCAAACTCTTCGAACCGGTGATCAGCTATCAACTGCTCGCCACGGCGCTGCTGATCGCCCTCATCGGAACGATCGCCGTGGCCGCCGGTGA	MTSSQEMAAHTDRAVKTSPSVADRWTRHRSSLLAVATIAVVAVIARFAFLDHRSEDYVDFYRRWYQFIEDNGGYRALRHQFSNYNVPYLYLLATTVWLKIPSLVAVKLIPIAFDVLLGWYVYRITRLRYPTGRLPLTAALVVVLLPTVVLNSSMWGQCDSGYAALAIGGLYHLMRGRSWTACALFGAAFAFKLQAVFLFPVLLLMVLRRKLPWQCLLAVPGMYLLLDVPALLLGAEPGKLLTVYLDQASLLHGEFIVTAPNAFQYLDSTPQVLQTLGIVLTGVSVLGLVGAAVLRRPNLTHLQLVLAAAVSALLVPFLLPNMHERYFYLADVLTVIAAFWLPRKLWFAPLLTQFASLFAYIPFLLLPYRLRDLTGNPDVVGGSGFAEPAPEIRLACVGDTSRPQPAGGARQTLRTGDQLSTARHGAADRPHRNDRRGRR	MNVEYSKIKKAVPILLFLFVFSLVIDNSFKLISVAIADDLNISVTTVSWQATLAGLVIGIGAVVYASLSDAISIRTLFIYGVILIIIGSIIGYIFQHQFPLLLVGRIIQTAGLAAAETLYVIYVAKYLSKEDQKTYLGLSTSSYSLSLVIGTLSGGFISTYLHWTNMFLIALIVVFTLPFLFKLLPKENNTNKAHLDFVGLILVATIATTVMLFITNFNWLYMIGALIAIIVFALYIKNAQRPLVNKSFFQNKRYASFLFIVFVMYAIQLGYIFTFPFIMEQIYHLQLDTTSLLLVPGYIVAVIVGALSGKIGEYLNSKQAIITAIILIALSLILPAFAVGNHISIFVISMIFFAGSFALMYAPLLNEAIKTIDLNMTGVAIGFYNLIINVAVSVGIAIAAALIDFKALNFPGNDALSSHFGIILIILGLMSIVGLVLFVILNRWTQSEK	97.56	gnl|BL_ORD_ID|1791|hsp_num:0	1835			795	936	tetracycline
BGC0000206.1|Chartreusin_2 # 1460 # 2233 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.709	BGC0000206.1|Chartreusin_2 	1460	2233	-	Loose	400	33.4982	Erm(30)	33.33	3001265	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGACACCTCCATGTACCACGCGTTCGCCGCGGTGGAGAGCCGGCACTGGTGGTTCCAGGGGCGTCGGCGGATCGTCGCCGCGCTGCTGCGGGACCAGCTGAGGGATGTCCGGCGAGCGAAGCCCGGTGGGCTGGACATCCTCGACGTCGGGTCGGGGACGGGCGAAATGGTCGAGATGCTGCGCGAGTTCGGGACCGTCACCGCACTCGACAGTTCCCCGCACGCCATCGACTACCTGCGGCAGAGACTGCCCGAGGGTGTGTCGGCCCGGCACGGCAGCATCCCCGAGGATCTGCCCCGCGACGAGATGTTCGACCTGGTGACCGCCTTCGACGTGGTCGAGCACCTCAACGACGACCTGGCGGCGCTGCGCGCGTTCCGCCAAGTACTGCCCACGGGCGGCCGCATGGCGCTCACCGTCCCCGCCTACCAGATGCTGTGGAGCCACCACGACGTCTACGCCGGGCACGTCAGGCGCTACCGCCGTGCGCAGCTGCGGGATCTCGTGCAGCGGGCCGGCGGCTTCCAGGTGGAACGCCTCGCCTACTTCAACTCGCTGCTGTTCCTGCCGGCCCTCGCGGCGAGGTCGGCGGGCCGCTGGCGGCGCCGGGTGTCGCCACGCGTGGCCGAGCGCGTCGATCCGCATCTGGCCCTGCCTTCCCCGCTGGTGAACCGGCTTCTGCTCGGGGTCTTCTCCTCCGAGGCCGGTCTGCTGTCACGCGTCGACCCGCCGTTCGGCGTCTCGCTCGTCGCGCTGTGCCGCGCCTGCTGA	MDTSMYHAFAAVESRHWWFQGRRRIVAALLRDQLRDVRRAKPGGLDILDVGSGTGEMVEMLREFGTVTALDSSPHAIDYLRQRLPEGVSARHGSIPEDLPRDEMFDLVTAFDVVEHLNDDLAALRAFRQVLPTGGRMALTVPAYQMLWSHHDVYAGHVRRYRRAQLRDLVQRAGGFQVERLAYFNSLLFLPALAARSAGRWRRRVSPRVAERVDPHLALPSPLVNRLLLGVFSSEAGLLSRVDPPFGVSLVALCRAC	MAMRDSIPRRADRDTLRRELGQNFLQDDRAVRNLVTHVEGDGRNVLEIGPGKGAITEELVRSFDTVTVVEMDPHWAAHVRRKFEGERVTVFQGDFLDFRIPRDIDTVVGNVPFGITTQILRSLLESTNWQSAALIVQWEVARKRAGRSGGSLLTTSWAPWYEFAVHDRVRASSFRPMPRVDGGVLTIRRRPQPLLPESASRAFQNFAEAVFTGPGRGLAEILRRHIPKRTYRSLADRHGIPDGGLPKDLTLTQWIALFQASQPSYAPGAPGTRMPGQGGGAGGRDYDSETSRAAVPGSRRYGPTRGGEPCAPRAQVRQTKGRQGARGSSYGRRTGR	76.49	gnl|BL_ORD_ID|1123|hsp_num:0	1224			123	249	narbomycin; methymycin; pikromycin
BGC0000206.1|Chartreusin_3 # 2239 # 3360 # -1 # ID=1_3;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.715	BGC0000206.1|Chartreusin_3 	2239	3360	-	Loose	550	160.999	PmrF	33.87	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCGCACCGACGCCGAAACGCCCCAGGCACACGACACGCCCGACCTGTATCGCGCGCTCGCCCTGGGTGACTACGTGCTGGGCCGGACGCCCCTGCACATCGCCGCCCGGACCGCCGGATTCTCCGCCGACGAGATGCTGCGCCTGGTGCGCTCACGCGTCGACGTTCCGGCCGACCCGGCACCAGGCCCTCCCGGACCCCGGGAGCCGCTGCTGTCGGTGGTCGTCCCGGTCTTCAACAACGCCACCACCCTGCGTGAACTGCACCGCCGTCTGCGCGGGGCGCTCACCCCGATCGGCACCTTCGAGATCCTGTTCGTCGACGACGGCAGCATCGACGGCTCGGCCGACCTCATCGGCGAACTGCACCGCGAGGACCCGTCGGTCCGGCTGCTCCGGCTGTCGCGCAACTTCGGCCAGCAGGCGGCCCTGAGCGCCGGGCTGGACGTCGCCCGGGGCGCGGCGGTCGTCATGCTGGACGCCGACCTCCAGGACCCGCCCGAGCTGATCGGCGACCTCGTCGAGCGCTGGCGGGCGGGCCACGAGGTCGTCTACATGGTCCGCAGGAACCGCAAGGAAGGGCCGCTCAAGCGCCTGGCCTACGCGGTCTTCTACCGGGTCTTCCGATACCTCGCGGACATCGAAGTGCCCCTGTCCAGCGGGGACTTCGCGCTCCTGGACCGCCGTGTGGTGGCCGTGCTGCGCTCGATGCCGGAGCGCAGCAGGTTCCTGCGCGGGTTGCGCAGCTGGTCGGGGTTCCGGCAGGCCGCCGTCGAGTACGACCGCGCCCGCCGGCCGTCCGGCGAGTCCCAGTACACCCTGCGCCGGCTGGCCAAGCTCGCCGCGGACGGACTGCTCGGCTTCTCCAGCGTTCCGCTGCGGCTGGTGTCCACGCTCGGCCTCGCGACCGCCGCCGCCGGAGCCGTGATGGTGGTCCTGGTGCTGCTGGCCCGGCTCAGCGCCTTGTCGCTGCCGGTGGGCTGGGCCTCCACGATCTCCGTGGTCCTCCTCGTCGGCGGAGCCCAGCTCACCACCATCGGCATGGTCGGCGCCTACATCGCGCGGATCTACCACGAGGTCAAGAAACGTCCTCTGTACATCGTCATGGAACGGCTGGGGTGA	MRTDAETPQAHDTPDLYRALALGDYVLGRTPLHIAARTAGFSADEMLRLVRSRVDVPADPAPGPPGPREPLLSVVVPVFNNATTLRELHRRLRGALTPIGTFEILFVDDGSIDGSADLIGELHREDPSVRLLRLSRNFGQQAALSAGLDVARGAAVVMLDADLQDPPELIGDLVERWRAGHEVVYMVRRNRKEGPLKRLAYAVFYRVFRYLADIEVPLSSGDFALLDRRVVAVLRSMPERSRFLRGLRSWSGFRQAAVEYDRARRPSGESQYTLRRLAKLAADGLLGFSSVPLRLVSTLGLATAAAGAVMVVLVLLARLSALSLPVGWASTISVVLLVGGAQLTTIGMVGAYIARIYHEVKKRPLYIVMERLG	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	115.84	gnl|BL_ORD_ID|1937|hsp_num:0	2014			27	936	polymyxin B
BGC0000206.1|Chartreusin_4 # 3402 # 4169 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGGAGG;rbs_spacer=3-4bp;gc_cont=0.704	BGC0000206.1|Chartreusin_4 	3402	4169	-	Loose	1900	25.409	acrD	27.27	3000491	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGCCTGATCGACCTGTCCTCCCCGATCGACGCCACGTCATGGGAGCCGGACCCGATCGAGCACTCGATCATGACCCCGGCGCAGGGGGCCCGGCACCTGGTCGCGGAGATGGAGCAGCACTTCGGCCTGTCCCTGGACCCCGACGACCTGCCGGACGGCGAGTTCCTCAACAACGACACGCTGACCCTGACGACCCACGTCGGCACCCATGTCGACGCCCCGACCCACTACGGCTCCACGGCGGCGTACGGGAAGCCGAAGACCATCGACCAGGTACCGCTGGAGTGGTTCTACCGTCCGGGCGTGGTGCTGGACCTCACGGCGGCCGGCGTGGGGAGCGTCGACGCCCGCTTCATCGCCGCCGAGCTCGACCGCGTCGGGCACGAGGTGCGGCCGTACGACATCGTGCTGCTGCGCACGGGGGCCGAGGAGTGGAGCGGTACGCAGCGCTACTTCACGGACTTCACCGGGCTGGACGGGTCGGCCGTGCACTACCTCCTCGACCTGGGGGTCCGGGTCATCGGCACGGACGCGTTCAGCCTCGACGCCCCGTTCACCCACATCATGGAGCGCTACGCCGACACCGGGGACCGGGCTCTGCTGTGGCCGGCGCACTTCGCGGGCCGGGAGCGGGAGTACTGCCAGATCGAGCGACTGGCCAATCTCGGTGCCCTGCCCTCCTCCGGTTTCTCGGTCGTCTGCTTCCCGGTGCGGGTCGCCCGTGCCGGAGCGGGCTGGGCACGCGCTGTCGCGGTCCTCGATTGA	MRLIDLSSPIDATSWEPDPIEHSIMTPAQGARHLVAEMEQHFGLSLDPDDLPDGEFLNNDTLTLTTHVGTHVDAPTHYGSTAAYGKPKTIDQVPLEWFYRPGVVLDLTAAGVGSVDARFIAAELDRVGHEVRPYDIVLLRTGAEEWSGTQRYFTDFTGLDGSAVHYLLDLGVRVIGTDAFSLDAPFTHIMERYADTGDRALLWPAHFAGREREYCQIERLANLGALPSSGFSVVCFPVRVARAGAGWARAVAVLD	MANFFIDRPIFAWVLAILLCLTGTLAIFSLPVEQYPDLAPPNVRVTANYPGASAQTLENTVTQVIEQNMTGLDNLMYMSSQSSGTGQASVTLSFKAGTDPDEAVQQVQNQLQSAMRKLPQAVQNQGVTVRKTGDTNILTIAFVSTDGSMDKQDIADYVASNIQDPLSRVNGVGDIDAYGSQYSMRIWLDPAKLNSFQMTAKDVTDAIESQNAQIAVGQLGGTPSVDKQALNATINAQSLLQTPEQFRDITLRVNQDGSEVRLGDVATVEMGAEKYDYLSRFNGKPASGLGVKLASGANEMATAELVLNRLDELAQYFPHGLEYKVAYETTSFVKASIEDVVKTLLEAIALVFLVMYLFLQNFRATLIPTIAVPVVLMGTFSVLYAFGYSVNTLTMFAMVLAIGLLVDDAIVVVENVERIMSEEGLTPREATRKSMGQIQGALVGIAMVLSAVFVPMAFFGGTTGAIYRQFSITIVAAMVLSVLVAMILTPALCATLLKPLKKGEHHGQKGFFAWFNQMFNRNAERYEKGVAKILHRSLRWIVIYVLLLGGMVFLFLRLPTSFLPLEDRGMFTTSVQLPSGSTQQQTLKVVEQIEKYYFTHEKDNIMSVFATVGSGPGGNGQNVARMFIRLKDWSERDSKTGTSFAIIERATKAFNQIKEARVIASSPPAISGLGSSAGFDMELQDHAGAGHDALMAARNQLLALAAENPELTRVRHNGLDDSPQLQIDIDQRKAQALGVAIDDINDTLQTAWGSSYVNDFMDRGRVKKVYVQAAAPYRMLPDDINLWYVRNKDGGMVPFSAFATSRWETGSPRLERYNGYSAVEIVGEAAPGVSTGTAMDIMESLVKQLPNGFGLEWTAMSYQERLSGAQAPALYAISLLVVFLCLAALYESWSVPFSVMLVVPLGVIGALLATWMRGLENDVYFQVGLLTVIGLSAKNAILIVEFANEMNQKGHDLFEATLHACRQRLRPILMTSLAFIFGVLPMATSTGAGSGGQHAVGTGVMGGMISATILAIYFVPLFFVLVRRRFPLKPRPE	24.59	gnl|BL_ORD_ID|1309|hsp_num:0	1427			738	924	
BGC0000206.1|Chartreusin_5 # 4160 # 5128 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.712	BGC0000206.1|Chartreusin_5 	4160	5128	-	Loose	500	26.1794	Vibrio cholerae varG	28.36	3004289	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	Subclass B1 Vibrio cholerae varG beta-lactamase	ATGACGGCACCGACCATGCGTTCCACCGAGCACTCGATCACCGTGGCGGCTCCGGCCCGGCGCGTGTACGACATCGTGGCCCGCGCCGCCGACTGGCCGCACCACTTCACGCCCACCCTGCACGTCGAGGTCCTGGAGTCCGGCGGCGACGAGGAACGCCTGCGCATCTGGGCCATCGCCAATGGCGAGGTGAAGTGCTGGACGTCCCACCGCGTCCTGGACCCGACGGCGCTGAGCGTCCGCTTCCGCCAGGAGGTCCCCGCTCCCCCGGTGGCCTTCATGAGCGGCGAATGGCGCATGACGCCCCTCGACGCCCACACCACCCGCGTGACGTTCCTGCACGAGTACGGTGCCGTCGACGACGATCCGCAGTCGCTGCGGTGGATCGACAGGGCCGTCGACAGCAACAGCGCCGAGGAGCTGGCCCGGCTCGGGAACGCCGCCGAACTGGCCGGCCGTATCGACGAACTCCTGCTCTCCTTCGAGGACTCGGTCGAGATCGCGGCGCCCGCAGGGGACGTCCACGACTTCCTCCGCGACGCGGGCGAGTGGCCGCGGCGCATCCCGCACGTGGACCGGGTGGAGCTGACCGAGGACGCCGGCGTGCAGCACATGGACATGGACACCCGTACCGCCGACGGCTCGGTGCACACGACGTCCTCGGTGCGGATCTGCCTTCCCCCCGACCGGATCGTCTACAAACAGGTCGTCACCCCGCTGCTGATGACCGCCCACACCGGTTCCTGGCACATCACGGCACGCCCGGAGGGCACGCTGGCCACGTCCCGCCACACTGTCCTGCTCGCCCCGGACCGGGTGCGCGAGGTGCTGGGCCCGGACGCCACCCTCGCCACCGCGCGGGACTTCGTCCGCCGGGCCCTCGGCCACAACAGCACCGTCACGCTGAAGCACGCCAAGGCGTACGCCGAGGCTCTCGAAGCCGGCACCGAGGAGGGCTCATGCGCCTGA	MTAPTMRSTEHSITVAAPARRVYDIVARAADWPHHFTPTLHVEVLESGGDEERLRIWAIANGEVKCWTSHRVLDPTALSVRFRQEVPAPPVAFMSGEWRMTPLDAHTTRVTFLHEYGAVDDDPQSLRWIDRAVDSNSAEELARLGNAAELAGRIDELLLSFEDSVEIAAPAGDVHDFLRDAGEWPRRIPHVDRVELTEDAGVQHMDMDTRTADGSVHTTSSVRICLPPDRIVYKQVVTPLLMTAHTGSWHITARPEGTLATSRHTVLLAPDRVREVLGPDATLATARDFVRRALGHNSTVTLKHAKAYAEALEAGTEEGSCA	MFVSHLSFPHLIEERKMKLSTLALAPITAALLTFNASAKGHDHDNQRAIFFPGETVQDTVKVEVEPSATQSLKLGQKINNLYERQFDNSQATVQKLGKNTYWIGVNYYNATVVVNEDSVLLIDPLGDGRIDALFKGVQSITNKPITTIMYSHYHLDHLGGGNQLVDLIKKNYPKVDKIRVIASQTVADKINQHAEVGENGVKTPKVPAPNDIYDLTKPQTVQFGSMKIKMMAPKGSGHTPDNTMILIPSDRVLHFADMINPDQLPFYNFAGAEHFHGYEEDLQSLLSKPLSKQWDFINGGHGNIGSKQDVKDLLEYIADIRTEVGKQLEVAPYTPVLSDGNHFVWFKRWQDEITNNVHTALANKYGHMYGFDSGVVETHAAMILADMIDH	82.56	gnl|BL_ORD_ID|2428|hsp_num:0	2842			582	783	meropenem
BGC0000206.1|Chartreusin_7 # 6144 # 6581 # 1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.703	BGC0000206.1|Chartreusin_7 	6144	6581	+	Loose	330	24.6386	AAC(6')-I-43	48.0	3004641	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGACCGAGACCGTGGTGCCGGGAACCATCGGCGAACTGCGCGCCCGAGTCGAGCAGTTCTACGCCGCACAGATGCGGCTCCTCGATTCGGGGGAGGCAGAAGCATGGGCGGACACGTTCACCGAGGACGCCGTCTTCTCGGCCAACGGGCGCAGCGAGCCCACGCGCGGGCGCACGGCCATCGCCGCCGCGGCGCGTCTCACGTCCGCCGAACTGGGCGCGGCCGGCCGGATCCGGCGGCACTGGATCGGCATGTCCGCGGTGGAGCCCGCAGGAGACGGCACGGTGCGGGTGGCGAGCTACGCGTTGATCATCGAGACGGAGGTCGGTGGCTCACCGAAGGTGCTCATGTCGACCACGTGTGACGACGTCCTGGTGGACGACGGTGGCCTGCGTGTGCGGCACCGCGTCGTCGCACGCGATGACATCGCCTCCTGA	MTETVVPGTIGELRARVEQFYAAQMRLLDSGEAEAWADTFTEDAVFSANGRSEPTRGRTAIAAAARLTSAELGAAGRIRRHWIGMSAVEPAGDGTVRVASYALIIETEVGGSPKVLMSTTCDDVLVDDGGLRVRHRVVARDDIAS	MIYNIINIADSEKNKEDAARILYSAFRGKGKDAWPTLDSAREEIAECIASPNICLGITLDDRLVGWGGLRPMYETTWELHPLVIDPDYQGNGLGRLLLSKIESTATTNRIIGIMLGTDDETLSTSLSMTDIDESNIFQEIKNIINIKNHPFEFYKKCGYIIVGIVPNANGYRKPDIWMWKNLEKKSG	77.54	gnl|BL_ORD_ID|4937|hsp_num:0	3340			135	210	kanamycin A; tobramycin
BGC0000206.1|Chartreusin_8 # 6658 # 7056 # 1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.697	BGC0000206.1|Chartreusin_8 	6658	7056	+	Loose	500	25.0238	Erm(50)	28.97	3007032	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGGGAGTCGTCAACTCCACGGTGGCGATAGCCGGCACCAGCGTGCTCCATGTCGGCCTGCGGGTGGGGCCGCTCACCTCGAACGCGATCGCCACCCTGCTCGCGACGACCCTGTCGTTCGCCGGGAACCGCTGGTGGACCTTCCGGCACCGCAGACGCAGCAACCTCGTCCAGGAGTACGCCCTCTTCTTCGTCCTGAACGGCGCCGGCCTGCTGATCCAGCTCCTCGCCATCGCGTTCGCCGTCCGGGTACTGGACCGGGACGACCCGGTGTCGTACCACGTGGCGCTGCTCGTCGGGGTGGCCGTGGCCTCGCTGGTCCGCTTCCTCAGCTACAAGAAGTGGGTGTTCCTCCCGAGGGAGCGGCCGGTCCGTGCGGGTGCGCGCAGGCCCGGGTGA	MGVVNSTVAIAGTSVLHVGLRVGPLTSNAIATLLATTLSFAGNRWWTFRHRRRSNLVQEYALFFVLNGAGLLIQLLAIAFAVRVLDRDDPVSYHVALLVGVAVASLVRFLSYKKWVFLPRERPVRAGARRPG	MPTYRPNKGRHENGQNYLVNEATIRRIVDLVPVNASVPVIEIGPGHGALTFPLQDRVLAAGGSLTAVEIDPASVRWLEKRLRPEVHLYEQDVLDFVLPDGPHVLVGNLPFHLTTAILRHVLHSPGWTHAVLLVQWEVARRRAGVGGATMMTAQWWPWVDFEQYGRVPSTHFRPRPTVDAGVLVIRRREEPLVDWSERARYASFVHDVFTGKGRGVADIVSRVVGRRRARRCAQVLREAGVPAHALPKQLDAGQWATLFTAVGC	50.19	gnl|BL_ORD_ID|4765|hsp_num:0	5762			96	414	roxithromycin; clarithromycin; clindamycin
BGC0000206.1|Chartreusin_9 # 7130 # 7915 # -1 # ID=1_9;partial=00;start_type=TTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.653	BGC0000206.1|Chartreusin_9 	7130	7915	-	Loose	400	38.5058	vanR gene in vanI cluster	30.19	3003728	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanR	TTGGAGATACGAATACTCGGCCCCATATCCATCGAACCGATCGGGACGGTGAGCACTCGACTCGCCCCCAAGCCACGCAAGATCCTGGCTCTGCTGCTCCTCAACGCGAACAAGATCGTATCGACTGCTTCACTCATGACCGAGCTCTGGGGCGAGACCCCGCCCAAGAGCGCGACCACGACCTTGCAGACCTATGTCCTGCACCTGCGCAAGGCACTTGGCGCCCTATGGGAAATCGATCTGCCTGACATAGCCAAGAACGTGCTCACCACACACACCAACGGCTACATGCTCAGCATCTCGCCCGGGACGGTCGACCTGCATGTGTACAACAAGCTCGTGGCCGATGGCCGGCGTGCCCTGGAAGAAGGGCAGATCGAACGCGGGGCCGCCCGTTTCGACGAGGCGCTGGCACTGTGGAGCGGTCCCCCGCTCGCCGACGTGCCCATCGGTCCGCTGCTGGAGGCGGAGGTGATGCGTCTGGAGGAGGACCGGCTCGGCATCCTGGAGGACCGGATCAGCGCGGACCTCCGGCTTGGCCGGCACCATCAACTGCTGGGCGAACTGACCTCGTTGGTCGCACAGCATCCCTTCCACGAGGGTCTGCACGAGAAGCTGATGGTGGCGCTGCACCGGTCCGGCCGGCGGCACCAGGCCCTGGACGTCTATCAGCGTCTGCGCTCGTCGCTCGTGGACGAGCTCGGCATCGATCCGTCGCCCAGGCTCCAGCGTCTGCACCAGTCCGTCCTCGCCTCCGACCCGAGGCTGGACAACGCGGCGGCCTGA	MEIRILGPISIEPIGTVSTRLAPKPRKILALLLLNANKIVSTASLMTELWGETPPKSATTTLQTYVLHLRKALGALWEIDLPDIAKNVLTTHTNGYMLSISPGTVDLHVYNKLVADGRRALEEGQIERGAARFDEALALWSGPPLADVPIGPLLEAEVMRLEEDRLGILEDRISADLRLGRHHQLLGELTSLVAQHPFHEGLHEKLMVALHRSGRRHQALDVYQRLRSSLVDELGIDPSPRLQRLHQSVLASDPRLDNAAA	MAANILIVDDEQAIADLVEVYLKNENYNLFKFYNGKDALDCIEKEKLDLAILDVMLPDVDGFSICRQIREKHNFPVIMLTAKEEEIDKITGLTLGADDYITKPFRPLELIARVKAQLRRFTKYNSAEPNQEEHVIAFSGLVLDMDTHECTLNEKKLSLTPTEFSILWVLCSNRGRVVSSEELFSEVWGDKYFTNSNNTVMVHIRHLREKMQDSAEHPKYIKTVWGVGYKIEK	112.50	gnl|BL_ORD_ID|2065|hsp_num:0	2246			471	630	vancomycin; teicoplanin
BGC0000206.1|Chartreusin_10 # 8278 # 9546 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.708	BGC0000206.1|Chartreusin_10 	8278	9546	+	Loose	750	187.193	Mycobacterium tuberculosis kasA mutant conferring resistance to isoniazid	34.67	3003463	protein variant model	F413L	n/a	isoniazid-like antibiotic	antibiotic target alteration	antibiotic resistant kasA	ATGGACTACTGTGTGGCGATAACCGGAATCGGAGTCCGGGCGCCAGGGGGAATCGGCACCAATGCGTTCTGGGAACTCCTGACGTCCGGTCGTACCGCAACACGCACGATATCTTTCTTCGACCCCTCCCCGTTCCGGTCCCGCGTCGCGGCCGAGTGCGATTTCGACGCGCGCGCCGAGGGCTTCACGCCCAAGGAACTGAGGAGGATGGACCGCGCCGCGCAACTGGGCGTCGCGGCCGCCCGCGAGGCCCTCGCCGACAGCGGCCTGGGTGGCGGCGGGCTGGATCCGGCGGACGTGTCCGTCACGGTGGGCAGCGCCGTCGGTTGCACCATGGGCCTGGAACAGGAGTACTCGACCGTCAGCGACGGCGGCCGGCAGTGGCTCGTCGACCACACCTACGCCGTGCCGCACCTGTACGGCCACTTCGTCCCGAGCTCGCTGGCCGCCGAAGTGGCCTGGGCCGTGGCGGCCGAGGGACCCGTGTCGGTCGTCTCGACGGGATGCACCTCCGGGCTCGACGCGATCGGCCATGCGTGCGGGCTGCTGCGGGAGGGAGCCGGGAAGGTCGCGGTGGCCGGTGCCACCGACGCGCCGATCTCCCCGATCACCGTCGCCTGCTTCGACGCCATCAAGGCCACCACGGCACGCAACGACGACCCGGAGCACGCATCCCGGCCCTTCGACCGCAGCCGGGACGGCTTCGTGCTGGGCGAGGGGAGCGCGTTCTTCGTCCTGGAGCCGCTGGAGGACGCTCGGCGCCGAGGGGCCCATGTGTACGCCACGATCCGGGGGTTCGCGTCCCGGTCGAACGCCTATCACATGACCGGTCTGCGGCCGGACGGCCGGGAGATGGCGGAGGCGATCACCGCGGCACTCGGACAGGCGCGGTTGCGGCCCGACGACATCGACTACGTCAACGCGCACGGCTCCGGCACCAGGCAGAACGACCGGCACGAGACGGCGGCGGTCAAGCGCAGCCTCGGCGCGCACGCCTTCGACGTCCCGGTCAGTTCCATCAAGTCGATGATCGGGCATTCGCTGGGTGCCATCGGGGCCATCGAGATCGCGGCGTGTGCGCTGGCCATCGAGCACGACGTCATCCCACCCACAGCCAACCTGGAGGAACCCGACCCCGACTGCGACCTCGACTACGTTCCCAAGACCGCGCGCGAGCAGCGGACCGACGCCGTGCTGACGGTGGGCAGCGGCTTCGGCGGATTCCAGAGCGCGATGGTGCTCGCCGCTCCGGGAGCGGCCGCCCGATGA	MDYCVAITGIGVRAPGGIGTNAFWELLTSGRTATRTISFFDPSPFRSRVAAECDFDARAEGFTPKELRRMDRAAQLGVAAAREALADSGLGGGGLDPADVSVTVGSAVGCTMGLEQEYSTVSDGGRQWLVDHTYAVPHLYGHFVPSSLAAEVAWAVAAEGPVSVVSTGCTSGLDAIGHACGLLREGAGKVAVAGATDAPISPITVACFDAIKATTARNDDPEHASRPFDRSRDGFVLGEGSAFFVLEPLEDARRRGAHVYATIRGFASRSNAYHMTGLRPDGREMAEAITAALGQARLRPDDIDYVNAHGSGTRQNDRHETAAVKRSLGAHAFDVPVSSIKSMIGHSLGAIGAIEIAACALAIEHDVIPPTANLEEPDPDCDLDYVPKTAREQRTDAVLTVGSGFGGFQSAMVLAAPGAAAR	MSQPSTANGGFPSVVVTAVTATTSISPDIESTWKGLLAGESGIHALEDEFVTKWDLAVKIGGHLKDPVDSHMGRLDMRRMSYVQRMGKLLGGQLWESAGSPEVDPDRFAVVVGTGLGGAERIVESYDLMNAGGPRKVSPLAVQMIMPNGAAAVIGLQLGARAGVMTPVSACSSGSEAIAHAWRQIVMGDADVAVCGGVEGPIEALPIAAFSMMRAMSTRNDEPERASRPFDKDRDGFVFGEAGALMLIETEEHAKARGAKPLARLLGAGITSDAFHMVAPAADGVRAGRAMTRSLELAGLSPADIDHVNAHGTATPIGDAAEANAIRVAGCDQAAVYAPKSALGHSIGAVGALESVLTVLTLRDGVIPPTLNYETPDPEIDLDVVAGEPRYGDYRYAVNNSFGFGGHNVALAFGRY	101.44	gnl|BL_ORD_ID|1968|hsp_num:0	1943			225	1239	isoniazid
BGC0000206.1|Chartreusin_11 # 9543 # 10769 # 1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.739	BGC0000206.1|Chartreusin_11 	9543	10769	+	Loose	500	35.8094	CPS-1	35.48	3003716	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CPS beta-lactamase	ATGAGTGCCAAGGTCGTGGTCACCGGGCTCGGTGTCGCCGCACCCAACGGGCTCGGCACACGCGCCTATTGGGAGGCGACGCTGCGCGGCCGCAGCGGGATCGCCCCGCTGAAGCGGTTCGACGCACGGGGCTACCCCGCCCGGCTCGCCGGCGAGGTACCCGGCTTTGAACCGGCCGAGCATCTGCCGGGCCGGTTGCTGCCGCAGACGGACCACATGACCAGGATGGCGCTGGTGGCGGCCGACTGGGCCCTGGCGGACGCGCGGGCCGATCCGGAGCGGCTCGCGGAGTTCTCGATGGGAGTGGTGACGGCCAGTTCCTCCGGAGGCTTCGAGTTCGGGCAGCGGGAGCTGGAGAAGCTGTGGAGCAAGGGCAGCCGGTACGTCAGCTCGTACCAGTCCTTCGCGTGGTTCTACGCCGTCAACACCGGCCAGATCTCCATCCGGAACGGCATGCGCGGCCCGAGCGGCGTCCTGGTGAGCGACCAGGCGGGCGGGCTGGACGCCGTGGCGCAGGCCCGCCGGCTGGTGCGCGAAGGGCTCGCACTGGTCGTATCCGGTGGCGTGGACGCAAGCCTGTGTCCCTGGGGCTGGGTCGCTCAGCTCAGCACCGGCCGGCTCAGCACCGGCGACGACCCACGGTCCGCGTATCTGCCGTTCAGCGCCGCGGCGCGCGGCTACGTGCCCGGCGAGGGCGGCGCGATCCTCGTGCTGGAGGAGGAGGGTGCCGCCGCTCGGCGCCGCCCGGGTGCGCCGTACGGCGAGATCGCGGGCTACGGCGCGACGTTCGACCCGCATCCGGACAGCGGGCGGCCGCCGCGGCTCCGCGACGCCATCGAGATCGCGCTCGGCGACGCCGGGCTCGACCCGTCCGACGTGGACGTCCTCTTCGCCGACGCCGCTGGACTGCCGGACCTGGACCGGGTGGAGGCCGAGGCGATCAGCGACGTCTTCGGGCCGCGTGGCGTCCCGGTCACCGCCCCCAAGACGATGACCGGACGGCTCTACTCGGGCGGCGCCGCCCTGGACCTGGCCGCAGCCCTGCTCTCGCTCAACGAGGGTGTCGTCCCGCCGACCGTCAACGTGGGGCGGCCGGCCCCCGAGTACGCGATCGACCTGGTCGTGCGGCCGAGGCCCGCCCCCTTGCGTGTCGCGCTGGTGCTCGCACGCGGGCACGGCGGCTTCAACGCCGCGATGGTCGTCCGCGCTCCCCACGCCCGCGACTGA	MSAKVVVTGLGVAAPNGLGTRAYWEATLRGRSGIAPLKRFDARGYPARLAGEVPGFEPAEHLPGRLLPQTDHMTRMALVAADWALADARADPERLAEFSMGVVTASSSGGFEFGQRELEKLWSKGSRYVSSYQSFAWFYAVNTGQISIRNGMRGPSGVLVSDQAGGLDAVAQARRLVREGLALVVSGGVDASLCPWGWVAQLSTGRLSTGDDPRSAYLPFSAAARGYVPGEGGAILVLEEEGAAARRRPGAPYGEIAGYGATFDPHPDSGRPPRLRDAIEIALGDAGLDPSDVDVLFADAAGLPDLDRVEAEAISDVFGPRGVPVTAPKTMTGRLYSGGAALDLAAALLSLNEGVVPPTVNVGRPAPEYAIDLVVRPRPAPLRVALVLARGHGGFNAAMVVRAPHARD	MRNLTLLFLLCLSFFGTAQTVTEPKNNPAEWSKDYEPFKIVGNLYYVGTYDLASYLIVTDKGNILINTGLADSYSTIKKNIEKFGFKYKDIKILTLTQAHYDHMGAMAQIKKETGAKLYVDEKDAAELKSGGKSDYEMGKYGVTFEPVHPDFLLKNNAKIKLGNTVLTLLHHPGHTKGSCSFLFETKEGNKNYKVLIANLPSIIIDHKFSDVKKYPTIQKDYGYTFEAMKKINFDVWVASHASQFDLHKKRKEGDSYNPKLFMDKENYFKRLKDLENDYLEKVKEDSAKK	140.69	gnl|BL_ORD_ID|2028|hsp_num:0	2231			327	501	
BGC0000206.1|Chartreusin_12 # 10835 # 11092 # 1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.682	BGC0000206.1|Chartreusin_12 	10835	11092	+	Loose	1000	23.8682	Clostridium perfringens mprF	35.71	3003773	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	defensin resistant mprF	ATGAGTGAACTGACCCTGGAACAACTCCGGACGATCATGACGGAGTGCGCGGGCGCGGCGGACGGCGTCGCACCTGACGACGACATCCGCGACATCGAGTTCGGGCTCCTCGGATACGACTCGATCGCGCTGCTGGAGACCGCGGCCCGGCTGGAACGCGACTACGGCATCAGCTTCGAGGACGAGGCCGTCGGGCAGGTCCGGACCCCCCAGGCCCTGCTGGACCTGGTCAACAACGCCCTCGCCGACGCCGCCTGA	MSELTLEQLRTIMTECAGAADGVAPDDDIRDIEFGLLGYDSIALLETAARLERDYGISFEDEAVGQVRTPQALLDLVNNALADAA	MWDSLKKSYRHLKNILGFVTDKRNYENIKKLLKNYKILSDISNIIVSVLVFLSGILLIISGIYPSIFYKIKFLDNIYSLSFLRFSHRASILIGLMLIMTSKEVFFKVKRAYYVTLTLLIVGGAFAFIKDLDYKEGIFILGVIILLILSKKSFYRKSIPIKVTKLSGILIVLSIVMIIFASFIHKFNIHFSKNYKYYIDFFHSTKGYLRIALFTYISFIIFVIIWYLTMPKIEDDERYMDADLEKVSKFFKEIDYGTIFSHLVYLKDKKVFWANEGESLIMYSKYKDKIIVLGDPIATKENLYSCIEEFQAFTNLYGYDVVFYEIEEKNFSTYHDAGYYFFKLGEEARIDLEEFNLIGSKKSAFRNTLRRVEREGYNFSIIEPPFNNEVVSQLKEISDKWLGDRKEKGFSLGWFSEDYIQRSPIAILKNEEENKIMGFVTIMDANDGGETVAIDLMRIDKDAPNASMDYLMLNLFLTFKEKGYKYFSLGEAPLSNVGFNTHSHLQEKLARLVYNSGNIFYSFDGLRRYKSKFSPIWQPRYLAYPKFMSLPEVFINLCLLIANSKERVEKK	14.94	gnl|BL_ORD_ID|2058|hsp_num:0	2282			1053	1179	defensin
BGC0000206.1|Chartreusin_13 # 11162 # 12310 # 1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.744	BGC0000206.1|Chartreusin_13 	11162	12310	+	Loose	700	75.485	oleI	31.79	3000866	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	ole glycosyltransferase	ATGCGCATCCTGGTCACCACCGCCCCGAGCCCGGGGCACTTCTTCCCACTCGTCCCCTTCGCCTGGGCGCTGCGTGCCCGTGGGCACCAAGTCCTGGTCACCATGCCCGAGCAGTTCATCGCCGAGGCCGGCCGGTCCGGTCTCCCCGCGGTGGCCTCGGTGCCGCCGATCGACCTGCGCGCCGCGATGGACTCGGGGGAGGGACCGCACCCGTCGCAGCGCGAGGGGGCCCGGGACGCCTCCGTGGAGCACATCGGCAGAGGCTTCGGCCGACTGTCGGAGCTGACCGTCGAGGGCACCGTCGCGGTCGCTGAACGGTGGGTGCCCGACCTCGTCGTGTCGGAGCCGACCGAGCACGCCGGGGCGGTCGCCGCGGCCCACCGCGGGGTTCCGCTGCTCCGGCACAACTGGGGGCTCGAACTGCCCCCGGAGACGGAGGAGATCGCCGCGGACCAGATGGCGCCCACCCTCGCCCGCCTCGGCCTGCCCGCGCCGGCGAAGGCCGGACTGCGGGTCGACATCTGCCCGGAGAGCCTCCAGCGGCCGCAGGCACGACCGGCGCAGCGGATGCGGTTCGTGCCCTACAGCGGGGCCGGCGTCACACCGCCCTGGTTGCTGGAAGAGCCCGACCGCCCCCGGGTCTGCGTGACGCTCGGCAGCGTCGTGCCGATGATCCACGGCGTGAAGGTCCTCAAGGAACTGGGGGAGGAACTCTCCGGCGACGACATGGAGACCGTCATCGCCGTTCCCGACCGCTTCGCCGACGAACTCGGCGCGCTTCCCCCGGGAGTGCGGGCGGCCGCCTGGCTGCCGCTCGGTCTTCTCCTCACCCACTGCACGGCGGTCGTGCACCACGGCGGGATCGGCACCGCGCTGACCGCCCTGGCCTTCGGACTGCCCCAGGTCGCCCTGCCCCACATGGGCGACCAGCACGCCACCGCCGATCGTCTCGCGGCGGCCGGAGCGGCGGCGGTCGTACGTCGCGAGGACATCACTCCCGCCGCCGTGGCCGAGGCCCTGCGCCGGGTCCGCAGCGAGCCGGGATACGCGGAGGGCGCCCGCGCGCTGAGGGCGGAGAACACCGCGGCGCCCGGTCTCGACGAAGTCGCGTGCCTCGCCGAGCAGTTGGCTGGCGCCCACCGGAAGTGA	MRILVTTAPSPGHFFPLVPFAWALRARGHQVLVTMPEQFIAEAGRSGLPAVASVPPIDLRAAMDSGEGPHPSQREGARDASVEHIGRGFGRLSELTVEGTVAVAERWVPDLVVSEPTEHAGAVAAAHRGVPLLRHNWGLELPPETEEIAADQMAPTLARLGLPAPAKAGLRVDICPESLQRPQARPAQRMRFVPYSGAGVTPPWLLEEPDRPRVCVTLGSVVPMIHGVKVLKELGEELSGDDMETVIAVPDRFADELGALPPGVRAAAWLPLGLLLTHCTAVVHHGGIGTALTALAFGLPQVALPHMGDQHATADRLAAAGAAAVVRREDITPAAVAEALRRVRSEPGYAEGARALRAENTAAPGLDEVACLAEQLAGAHRK	MTSEHRSASVTPRHISFFNIPGHGHVNPSLGIVQELVARGHRVSYAITDEFAAQVKAAGATPVVYDSILPKESNPEESWPEDQESAMGLFLDEAVRVLPQLEDAYADDRPDLIVYDIASWPAPVLGRKWDIPFVQLSPTFVAYEGFEEDVPAVQDPTADRGEEAAAPAGTGDAEEGAEAEDGLVRFFTRLSAFLEEHGVDTPATEFLIAPNRCIVALPRTFQIKGDTVGDNYTFVGPTYGDRSHQGTWEGPGDGRPVLLIALGSAFTDHLDFYRTCLSAVDGLDWHVVLSVGRFVDPADLGEVPPNVEVHQWVPQLDILTKASAFITHAGMGSTMEALSNAVPMVAVPQIAEQTMNAERIVELGLGRHIPRDQVTAEKLREAVLAVASDPGVAERLAAVRQEIREAGGARAAADILEGILAEAG	90.09	gnl|BL_ORD_ID|1684|hsp_num:0	1824			762	1206	oleandomycin
BGC0000206.1|Chartreusin_15 # 13571 # 14503 # 1 # ID=1_15;partial=00;start_type=ATG;rbs_motif=3Base/5BMM;rbs_spacer=13-15bp;gc_cont=0.751	BGC0000206.1|Chartreusin_15 	13571	14503	+	Loose	700	27.335	ACT-81	27.5	3006275	protein homolog model	n/a	n/a	carbapenem; cephalosporin; cephamycin; penam	antibiotic inactivation	ACT beta-lactamase	ATGAGCGGGCCGGGAAAGGATCCGGACCGGGCAACGCCCACGCGGCGGCCCGCCCTGGTTGTCGGTGCGGGCGGACTCATGGGCCGGGCACTGTGCCAGCGGCTGCGCGCGAGCGGAGCCGAGGCCGTCGCCGCCACGCGCGACACACCCCCGCTGGTCCGGCCCGACGGAACCCCCGCCCCGGCGCTGCGCGCCGCGGGCGTCGTCCACTACCTCGCGACGAGCGTGACCCCGGGCCTCGCCGAGACCCACCCCGAGCGCGTAGCCGCAGACCACGAGACGTTCGTACGGACTCTGGACGCACTCGCGACCGTCGAGAAGCCGCCGTTGGTCGTGCTGGCCAGCACCGGCCTGACGGTCAGTGAGTCCGGCGACGGCAGGCCGTGCACCGAGGACGCGGAGGCCCTGCCCAAGTCGGCGTACGCGAGGGCCAAGCTCGCCCTGGAGCGGGAGCTGCTGTACCGCTCGCCGCTCGTGCCGGGGATGGTCGTGCGGATGACCAACGTGTACGGCCCCGGGCACGCGCTGCGCCGCGGGTACGGCGTCGTCGCCCACTGGCTGGCCGCCGTCGCGCAGGGACGTCCGCTGGAGCTGTACGGCGACCCGGACACCACCCGGGACTACCTCTACGTCGACGACGCGGTGGCCGCACTGGCCGGGCTCGGCCCGGAAGCGGCCGACCTGCCGTTCGACGTCGTCAACATCGGGTCGGGGGAGGCGACCACGCTCGGCCGGCTGCTCGGCGTCGTCCGTGAGGTGACCGACCGGGAGTTGACCGTCCGGCTGCGGCCCGGCAGGGGGTTCGACCAGCCCGCCAACCTCCTCGACGTCGACCGGGCACACCGGCGGCTCGGCTGGCGGGCGCGCACACCGCTCGCCGTGGGCCTGGAACGCACCTGGCGTGCGCTGAACGGTACGGCGGTGGCCCCGTGA	MSGPGKDPDRATPTRRPALVVGAGGLMGRALCQRLRASGAEAVAATRDTPPLVRPDGTPAPALRAAGVVHYLATSVTPGLAETHPERVAADHETFVRTLDALATVEKPPLVVLASTGLTVSESGDGRPCTEDAEALPKSAYARAKLALERELLYRSPLVPGMVVRMTNVYGPGHALRRGYGVVAHWLAAVAQGRPLELYGDPDTTRDYLYVDDAVAALAGLGPEAADLPFDVVNIGSGEATTLGRLLGVVREVTDRELTVRLRPGRGFDQPANLLDVDRAHRRLGWRARTPLAVGLERTWRALNGTAVAP	MMKKFLCCALLLSTSCSVLAAPMSEKQLADVVERNVTPLMKAQGIPGMAVAVIYQGQPHYFTFGKADIAANKSVTPRTLFELGSISKTFTGVLGGDAIARGEISLGDPVTKYWPDLTGKQWQGIRMLDLATYTAGGLPLQVPDEVTDNASLLRFYQNWQPQWKPGTTRLYANSSIGLFGTLAVKPSGMNYEQAMTTRVFKPLKLDHTWINVPKAEETHYAWGYRDGKAVHVSPGMLDAEAYGVKTNVQDMASWVMANMAPDALQDTSLKQGITLAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVGGSDNKVALAPLPAREVSPPVPPVKASWVHKTGSTGGFGSYVAFIPEKQLGIVMLANKSYPNPARVETAYRILDALQ	81.36	gnl|BL_ORD_ID|3133|hsp_num:0	4171			0	333	
BGC0000206.1|Chartreusin_16 # 14500 # 14769 # 1 # ID=1_16;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.763	BGC0000206.1|Chartreusin_16 	14500	14769	+	Loose	450	25.0238	AAC(3)-IIIa	40.0	3002536	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	GTGAACGTCCCGGCGAGCGGCGACCGGAGCACCACGACACGCCGCTCGTGGTCCTGGCCGGGCGAGCCGGAGCGGCTGGAGGCCGTGCCCGACGCGGCACCCGCGCCGGACCTCGGCGACCACCCGCCCGCCCACGCCCCCGGCGACGGGCTGACCACCCTGGCCGGACTCGTACGCGAGATCCTCACCCGCCCCCTGTGCCGGACGCCCGGCACGCAGCGGACCGGCCGGCGAGAGCACATCGATCCGACAGAAGGCCATCGACCATGA	MNVPASGDRSTTTRRSWSWPGEPERLEAVPDAAPAPDLGDHPPAHAPGDGLTTLAGLVREILTRPLCRTPGTQRTGRREHIDPTEGHRP	MTDLNIPHTHAHLVDAFQALGIRAGQALMLHASVKAVGAVMGGPNVILQALMDALTPDGTLMMYAGWQDIPDFIDSLPDALKAVYLEQHPPFDPATARAVRENSVLAEFLRTWPCVHRSANPEASMVAVGRQAALLTANHALDYGYGVESPLAKLVAIEGYVLMLGAPLDTITLLHHAEYLAKMRHKNVVRYPCPILRDGRKVWVTVEDYDTGDPHDDYSFEQIARDYVAQGGGTRGKVGDADAYLFAAQDLTRFAVQWLESRFGDSASYG	32.84	gnl|BL_ORD_ID|1736|hsp_num:0	1879			198	273	neomycin; dibekacin; sisomicin; kanamycin A; tobramycin; paromomycin; lividomycin; 5-episisomicin; gentamicin
BGC0000206.1|Chartreusin_17 # 14766 # 15086 # 1 # ID=1_17;partial=00;start_type=ATG;rbs_motif=AGxAGG/AGGxGG;rbs_spacer=5-10bp;gc_cont=0.698	BGC0000206.1|Chartreusin_17 	14766	15086	+	Loose	450	23.0978	CVI-1	52.63	3006924	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CVI beta-lactamase	ATGAGAGAGAAGCCGATGCTCGTCTTCATCAACCGGTTCACCGTCAGCGGCGATCCGCTCGAGTTCGAGCGCGCCTTCGCCGAGACCGCGGCCCACCTCGCGCGACAGCCGGGGTTCATCCGGTACCGCCTGGTCCGCTCGACGGAAGACCCGCACTCCTACGCCAACGTGGCCGAATGGGAGACGGCGGCCGCCCTGCGCGAGGCCTTGCGCGGGCCGGAGTTCGACGACCACGCGCGCCGGCTGCGTGAGCTGGCGCGCAGCGAGCCACAGTTCTACGACGTGGTCACCGAGACCGACGCCATCCGATCGCGGCGCTGA	MREKPMLVFINRFTVSGDPLEFERAFAETAAHLARQPGFIRYRLVRSTEDPHSYANVAEWETAAALREALRGPEFDDHARRLRELARSEPQFYDVVTETDAIRSRR	MRTVFGFAGALLGLAAAACAAQGGLALKHLKGGVYVVEDGYYAKENSVVYVGAEHVTVVGATWTPDTARELARQIRAVTYKPIAEVVNPNYHPDRAGGNAYWKSIGARIVSTRQTADEMRRGWDEVVAFTRRGFPDYPALPVSLPDREHPGDFELQDGRIKAFHLGAAHTRDGIFIHFPQERVLYGNCILKQELGNLSYADLNEYPKTLERLKLSELDFDTVIAGHLDALHGPELIDHYQRLLKRQASDAAAERS	41.57	gnl|BL_ORD_ID|3506|hsp_num:0	4575			669	726	
BGC0000206.1|Chartreusin_18 # 15088 # 16086 # 1 # ID=1_18;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.645	BGC0000206.1|Chartreusin_18 	15088	16086	+	Loose	1200	45.8246	arnA	23.75	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGACGCGCCTGCTCGTGACCGGCGGTGCCGGGTTCATCGGTGCCAACTTCGTGCACCACACGCTGACCACACGACCCGAGTTCGAGATCTGCGTCCTGGACGCGCTGACCTACGCCGGCAACCGCGACAACCTCAAGTCCGTGGCCGGCGACATCCGCTTCGTCGAAGGCGACATCTGCGACACGGAACTCGTCGACCGCCTCGTCGCCGACGCCGACCTCGTCGTCCACCTGGCCGCCGAATCGCACGTCGACAACTCGCTGCGTGACCCCGAACCGTTCGTCCGTAGCAACGTCATGGGGACCTACGTCCTGCTGGAGGCCGTGCGCCGGTACGACCGGCGCTTCCATCACATCTCCACCGACGAGGTCTTCGGCGACCTCCCGCTCGACTCCGAGGAGAAGTTCACCGAGGCGAGCCCCTACAACCCGTCGAGCCCCTACTCGGCGACCAAGGCGAGCTCCGACATGCTGGTCCGGGCATGGGTGCGCTCCTTCGGGGTGGCGGCGACGCTGTCGAACTGCGCCAACAATTACGGGCCCTATCAGCACGCGGAGAAATTCATCCCGCGTCAGGTCACCAACGTCCTCACCGACCGGCTGCCGAAGCTGTACGGGAGCGGCCGCAACGTCCGGGAATGGACGCATGTCGAGGACCACAACGAGGCCGTCCATCTCATCCTGGAAAAGGGCGGGATCGGCGAGACCTATCTCATCGGATCCGGTTGCGAGATGAGCAACAAAGCGATTGTAAAAATACTCCTCGAACTCATGGGAAAACCGGTGGACCGGTATGAGGAGATCCTCGACAGACCGGGCCACGATCTTCGTTATGCGAACGACTCGTCGAAGCTGCGGACCCGGCTCGGCTGGCAGCCGCGTCATCGGAGCCTTCGCTCCGGGCTCGCCGCGACCATCGACTGGTATCGAGAAAACCCCTGGTGGTGGGCGTCGCGCAAGGACGCCGTCGAGAGCGCGTACGACGCATCGGGCAGGTAG	MTRLLVTGGAGFIGANFVHHTLTTRPEFEICVLDALTYAGNRDNLKSVAGDIRFVEGDICDTELVDRLVADADLVVHLAAESHVDNSLRDPEPFVRSNVMGTYVLLEAVRRYDRRFHHISTDEVFGDLPLDSEEKFTEASPYNPSSPYSATKASSDMLVRAWVRSFGVAATLSNCANNYGPYQHAEKFIPRQVTNVLTDRLPKLYGSGRNVREWTHVEDHNEAVHLILEKGGIGETYLIGSGCEMSNKAIVKILLELMGKPVDRYEEILDRPGHDLRYANDSSKLRTRLGWQPRHRSLRSGLAATIDWYRENPWWWASRKDAVESAYDASGR	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	50.15	gnl|BL_ORD_ID|1513|hsp_num:0	1643			951	1950	polymyxin B
BGC0000206.1|Chartreusin_20 # 17690 # 18082 # -1 # ID=1_20;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.636	BGC0000206.1|Chartreusin_20 	17690	18082	-	Loose	280	55.4546	FosA7.5	30.71	3005162	protein homolog model	n/a	n/a	phosphonic acid antibiotic	antibiotic inactivation	fosfomycin thiol transferase	ATGGCCGTGGAACTGAACCACACCATCGTTCTGGTGAAGGACAAGGACGCCTCGGCAACGTTCATGGCCGACCTTCTCGGCCTGCCGAAGCCGAAGGAGATGGGCCCGTTCGCGGTACTGCAACTCGCCAACGACGTGTCGATCGACTTCATGGACTTCCGGGGCGAGGGTGACATAGTTCCGGGACACTGCGCATTCCTGATCAGCGACGAGGAGTTCGACCAGATCTTCGGACGCATTCGCGAGGGCGGCATCGAGCACTGGGCGGACCAGTACCACCGGGAGCCCGGCCGGATCAACGACCGTGACGGTGGGCGCGGGGTCTACTTCGAGGATCCGAGCGGGCACAACATGGAGATCATGACCCGGCCCTACGGCAGCGGCGGGGCGTAG	MAVELNHTIVLVKDKDASATFMADLLGLPKPKEMGPFAVLQLANDVSIDFMDFRGEGDIVPGHCAFLISDEEFDQIFGRIREGGIEHWADQYHREPGRINDRDGGRGVYFEDPSGHNMEIMTRPYGSGGA	MLQSLNHLTLAVSNLQSSLTFWRDLLGLQLHAEWGTGAYLTCGDLWLCLSYDVSRSYVAPQKSDYTHYAFSIAPEDFEPFSYKLKQSGVTVWKDNKSEGQSFYFLDPDGHKLELHVGDLASRLAQCRERPYSGMRFGPGK	92.86	gnl|BL_ORD_ID|2870|hsp_num:0	3886			0	342	fosfomycin
BGC0000206.1|Chartreusin_21 # 18098 # 18547 # -1 # ID=1_21;partial=00;start_type=TTG;rbs_motif=AGGAG;rbs_spacer=5-10bp;gc_cont=0.633	BGC0000206.1|Chartreusin_21 	18098	18547	-	Loose	450	27.7202	cphA5	27.78	3003101	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	CphA beta-lactamase	TTGACTGCGGCCGACAACAAGAAGCGCTGTCTCGAGATGGTCGACGCATGGAATCGCGGGGAGCTCGGCGGAGTGACGGCGCACTGGTCACCGGACGTCGTCCATCACTCCGAGGAAAGGATCGTGCCGAACGAGGAAATGGTCCTCCGCATGGAATCCGGCCTGACGGCTTTTCCCGATGTGCGTCTCGACGTCAGGAGTGTGCTGGCCGAGGACGATCGGGTCAGCATGCGGATCAGTGTCACCGCCACACACACGGGCCCGTTCATGGACATCGCTCCGACGAACCGGACGGTGACCTGGCACACCGCGGAGGAATTCCGCTTCGTCGACGGCAAGGTCGTCGAGCACTGGGATGTCATCAACTACATGCCGATGCTGCGGGAGTTGAACATGGTCGGCTCCGACGTGCGCGGCTGGGGGACGGCCGAGCAGCAGGTCTCCCGATAG	MTAADNKKRCLEMVDAWNRGELGGVTAHWSPDVVHHSEERIVPNEEMVLRMESGLTAFPDVRLDVRSVLAEDDRVSMRISVTATHTGPFMDIAPTNRTVTWHTAEEFRFVDGKVVEHWDVINYMPMLRELNMVGSDVRGWGTAEQQVSR	MMKGWIKCGLAGAVVLVASFWGGSVHAAAISLTQVSGPVYVVEDNYYVKENSMVYFGAKGVTIVGATWTPDTARELHKLIKRVNNKPVLEVINTNYHTGQAGGNAYWKSIGAKVVSTRQTRDLMKSDWAEIVAFTRKGLPEYPDLPLVLPNVVHDGDFNLQEGKVRAFYAGPAHTPDGIFVYFPDQQVLYGNCILKEKLGNLSFADVKAYPQTLERLKAMKLPIKIVVGGHDSPLHGPELIDHYQALIKAATHS	58.66	gnl|BL_ORD_ID|1468|hsp_num:0	1605			249	516	
BGC0000206.1|Chartreusin_22 # 18677 # 19348 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=GGAGG;rbs_spacer=5-10bp;gc_cont=0.722	BGC0000206.1|Chartreusin_22 	18677	19348	+	Loose	570	25.7942	AAC(3)-IId	29.63	3004623	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGACGTATCTGGTGACCGGCGCGTCAGGACACGTCGGCAGAGAGGTGACACGGCAATTGGCGGCGGCGGGGCACGAAGTGCGGGCGATGACCCGTACCCCGGGGCGGACCCCCGCCCCCGACGACGTAGAGGTCGTCGCCGGCGACCTGACCCGGCCGGACAGCCTGGACGAGGCGTTGCGGGGGATCGAGCGGATGTATCTGTTCCCGGTGCCGGAGACGGCGTCCGAAGTCGTCGCACGGGCGGTGCGGGCCGGCGTGCGCCGCATCGTGGTGCTGTCGTCCAGCTCGGTGCACGACGAGACCACCCACAGCGGGGCCCACCACCGGGCAGTGGAACGCGCCGTCGAGGACAGCGGCGTCGAGTGGACCTTCGTACGGCCCGACGAGTTCGCCAACAACCTGCTGTGGAAGTGGGGGCACTCGATCCGCGCCGAGGGCGTGGTCCGTGCTCCGTATCCCGAGGCCCGGCGCGCGCTGATCCACGAGAGGGACGTGGCGGCGGTGGCGGCCGCGGCCCTGATGACGGACGGTCACGCCGGCGCCCGCTACGAGCTGACCGGACCAGAACTGCTGGACCAGCCGGAGCAGGTCGCCCGTATCGCCGGGGTCACGGGCACCGGCATCCGCTTCGAGGAGGTGACCCCGCGGGGCCGCGCGGGAGGAGAATGA	MTYLVTGASGHVGREVTRQLAAAGHEVRAMTRTPGRTPAPDDVEVVAGDLTRPDSLDEALRGIERMYLFPVPETASEVVARAVRAGVRRIVVLSSSSVHDETTHSGAHHRAVERAVEDSGVEWTFVRPDEFANNLLWKWGHSIRAEGVVRAPYPEARRALIHERDVAAVAAAALMTDGHAGARYELTGPELLDQPEQVARIAGVTGTGIRFEEVTPRGRAGGE	MHTRKAITEALQKLGVQTGDLLMVHASLKAIGPVEGGAETVVAALRSAVGPTGTVMGYASWDRSPYEETLNGARLDDEARRTWLPFDPATAGTYRGFGLLNQFLVQAPGARRSAHPDASMVAVGPLAETLTEPHELGHALGEGSPVERFVRLGGKALLLGAPLNSVTALHYAEAVADIPNKRWVTYEMPMLGRDGEVAWKTASDYDSNGILDCFAIEGKPDAVETIANAYVKLGRHREGVVGFAQCYLFDAQDIVTFGVTYLEKHFGTTPIVPPHEAVERSCEPSG	77.97	gnl|BL_ORD_ID|2106|hsp_num:0	3322			657	858	dibekacin; sisomicin; netilmicin; tobramycin; 6'-N-ethylnetilmicin; 2'-N-ethylnetilmicin; gentamicin
